Archive | May, 2011

Size isn’t everything, or is it? Nano or non-nano

Is the “nano” label just marketing buzz and PR puff? You might think so given the huge number of products and press releases that exist where this little prefix, from the Greek meaning dwarf, is used instead of a more everyday description. Particles become far more interesting to consumers and grant-awarding peers when they become […]

Continue Reading

Going Global: Partnering and Investing in International Life Sciences

I will be presenting in an upcoming webinar: Going Global Partnering and Investing in International Life Sciences Today, successful life sciences companies are feverishly evaluating international partnerships in search of places that are rapidly expanding. Some make the costly mistake of only using market size as the deciding factor, which is often misleading. Success in […]

Continue Reading

Molecular Templates to present preclinical data of ETB platform technology at 5th RNAi and miRNA World Congress

Molecular Templates, Inc., a biopharmaceutical company focused on the discovery and development of a new class of small biologic therapies called Engineered Toxin Bodies (ETB), announced today that it will present preclinical data in a poster presentation at the 5th Annual RNAi and miRNA World Congress in Boston, MA during April 26-27, 2011. In a […]

Continue Reading

PhDs in questions

George Whitesides from Harvard University and John Deutch from MIT initiated the debate in a Comment published in the first 2011 issue of the journal Nature. In an issue mostly dedicated to chemistry (remember, 2011 is International Year of Chemistry), they advocate several changes chemical research in universities should undergo in order to “solve big […]

Continue Reading